BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Putting Patients First: The Quest to Make Anticancer Cell Therapy Accessible to All

With the inauguration of a new state-of-the-art cell therapy lab in early 2022, BeiGene is looking to broaden collaboration and expand ...

July 12, 2023 | News

NTHU Hospital BOT Project in Taoyuan with over NT$10 Billion of Investment by KMU

Guests attending and witnessing the BOT contract signing ceremony included Deputy Premier of the Executive Yuan Wen-tsang Cheng (鄭文燦), Minister of Fi...

July 10, 2023 | News

Gilead Sciences and IAS Honor Global Healthcare Providers for Stigma-Free HIV Services

The 2023 Me and My Healthcare Provider (MMHCP) campaign, supported by Gilead for the second year running, honours frontline workers providing exemplary inc...

July 05, 2023 | News

IMBdx Expands Targeted Therapies Agreement after Successful Prostate Cancer Genomic Profiling

The collaboration aims to improve accessibility to targeted therapies for mCRPC patients in international markets outside the US. Traditional tissue biopsi...

June 09, 2023 | News

Acepodia Secures $100 Million Series D Financing to Advance

Series D led by Digital Mobile Venture with participation from additional existing investors Funds will support expansion and progress of oncology pipelin...

June 07, 2023 | News

EirGenix's Breast Cancer Biosimilar EG1206A Meets Phase 1 Trial Goals

Comparing EG1206A to Roche's Perjeta® US and EU, results of the clinical data analysis show that the main test indicators have met the pharmacokinetics...

May 08, 2023 | News

Formosa Pharmaceuticals and AimMax Therapeutics Submit NDA to US FDA for APP13007 for Post-Operative Pain and Inflammation after Ocular Surgery.

This proprietary homogeneous nanosuspension has a solution-like appearance which offers great comfort to the eyes and enhanced drug penetration into ocular...

May 05, 2023 | News

Why Pharma and Medtech manufacturers are striving for digital maturity

Why pharma and medtech manufacturers are striving for...

April 25, 2023 | News

BIO Asia-Taiwan 2023: Asia's Largest Biotech Gathering

BIO Asia–Taiwan 2023 - Register Now Asia’s largest bioindustry-focused gathering, BIO Asia–Taiwan 2023, will be held July 26th t...

April 18, 2023 | News

Bora Pharmaceuticals and Celltrion Partners to Expand OSD capabilities in APAC market

The range of oral dosage form products will be manufactured at Bora’s Zhunan Site, which is one of the largest US FDA and MHRA-approved pharmaceutica...

April 10, 2023 | News

Taiwan's Compal Electronics Launches "AblatePal" RF Ablation System and "BreathePal" Bilevel Ventilator in Medical Device Market

The "AblatePal" RF ablation system uses the heat energy generated by electrical resistance when the current passes through the tissue to cauterize the tumo...

April 07, 2023 | News

AnnJi Pharma and Avenue Therapeutics Enter Licensing Agreement for Clinical Asset AJ201 to Treat Kennedy's Disease.

Under the terms of the license agreement, AnnJi will receive upfront payments of $3 million and is entitled to receive future development, regula...

March 13, 2023 | News

BRIM appoints Andrew Lin as Chairman and Dr. Wen Chyi Shyu as CEO, secures $18M in Series E funding, and advances clinical trials for Dry Eye Disease and Neurotrophic Keratitis treatments

What led to the decision to elect Andrew Lin as the new Chairman of the Board, and how do you believe he will contribute to BRIM's continued succ...

March 01, 2023 | Opinion

BRIM Biotechnology announces new leadership team

BRIM Biotechnology, Inc. (BRIM, TPEx 6885), a clinical-stage company developing novel regenerative therapies to help combat and cure ophthalmology and...

February 21, 2023 | News

Stay Connected